The FDA is aware that Baxter Healthcare Corporation has issued a letter to affected customers recommending certain Spectrum infusion pumps be removed from where they are used or sold. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available.
